DAWN Stock Ownership Activity
DAY ONE BIOPHARMACEUTICALS I 13F holders
No value investing guru has made any change to the DAY ONE BIOPHARMACEUTICALS I (DAWN) position according to the gurus' latest SEC quarterly report(s).
Which gurus or hedge funds are buying DAWN now?
According to the latest SEC filing(s) DAY ONE BIOPHARMACEUTICALS I (DAWN) has not been purchased by any super investor.
To see more about who is investing in DAY ONE BIOPHARMACEUTICALS I (DAWN), please go to the DAWN ownership page.
2023 Q2
(1 result)
Current price: $14.62
22.45%
Reported price*: $11.94
2022 Q3
(1 result)
Current price: $14.62
27.01%
Reported price*: $20.03
2022 Q2
(1 result)
Current price: $14.62
18.32%
Reported price*: $17.90
2021 Q4
(1 result)
Current price: $14.62
13.24%
Reported price*: $16.85
2021 Q3
(1 result)
Current price: $14.62
38.39%
Reported price*: $23.73
2021 Q2
(1 result)
Current price: $14.62
35.79%
Reported price*: $22.77
6 of 6
Shares, change to shares, sold shares - split-adjusted.
Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.
Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.